Active Ingredient History
3,4-Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy ; and molly or mandy, is a potent empathogen–entactogen with stimulant properties primarily used for recreational purposes. The desired effects include altered sensations, increased energy, empathy, and pleasure. When taken by mouth, effects begin in 30 to 45 minutes and last three to six hours. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alcoholism (Phase 1)
Amphetamine-Related Disorders (Phase 1)
Anorexia (Phase 2)
Anxiety (Phase 2)
Anxiety Disorders (Phase 2)
Autism Spectrum Disorder (Early Phase 1)
Binge-Eating Disorder (Phase 2)
Cognition Disorders (Phase 3)
Cognitive Dysfunction (Phase 3)
Combat Disorders (Phase 2)
Healthy Volunteers (Phase 1)
Interpersonal Relations (Early Phase 1)
Ischemic Stroke (Phase 3)
Liver Diseases (Phase 1)
Metabolism (Phase 1)
Mood Disorders (Phase 1)
Neoplasms (Phase 2)
Pharmacokinetics (Phase 1)
Phobia, Social (Phase 2)
Social Cognition (Early Phase 1)
Social Interaction (Early Phase 1)
Stress Disorders, Post-Traumatic (Phase 3)
Substance-Related Disorders (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue